Max Robotics — Global Service Robot Directory + US Certification

About

Daniela Greto is a leading clinical researcher in the field of stereotactic body radiotherapy (SBRT), with a particular focus on robotic radiosurgery using the CyberKnife platform. Her work centers on expanding the applications of high-precision radiation to challenging anatomical sites, including recurrent prostate cancer, early breast cancer, cardiac malignancies, and oligometastatic disease. Greto’s major contributions include demonstrating the feasibility and biochemical control of robotic stereotactic retreatment for previously irradiated prostate cancer patients—a study that has garnered 50 citations and remains a key reference in the field. She also led the phase II ROCK trial (NCT03520894), investigating preoperative robotic radiosurgery for early breast cancer, which earned 29 citations and highlighted the advantages of treating a well-defined target before surgery. Her work on SBRT for cardiac malignancies (23 citations) and liver oligometastases from colorectal cancer (17 citations) has helped establish stereotactic techniques as viable options for traditionally radioresistant or high-risk sites. With over 130 citations across her most-cited papers, Greto has significantly advanced the evidence base for robotic radiosurgery, offering new hope for patients with recurrent, metastatic, or inoperable tumors.